Remdesivir Available Phase N/A Trials for Novel Coronavirus Infectious Disease (COVID-19) / SARS-CoV2 Infection

IndicationsStatusPurposePhase
AvailableNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT04302766Expanded Access Remdesivir (RDV; GS-5734™)
NCT04323761Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)